Ocular Therapeutix

$17.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.56 (-3.19%) As of 7:11 PM UTC today

Why Robinhood?

You can buy or sell OCUL and other stocks, options, and ETFs commission-free!

About OCUL

Ocular Therapeutix, Inc. Common Stock, also called Ocular Therapeutix, is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA. The listed name for OCUL is Ocular Therapeutix, Inc. Common Stock.

CEO
Antony Mattessich
Employees
161
Headquarters
Bedford, Massachusetts
Founded
2006
Market Cap
1.26B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.26M
High Today
$18.16
Low Today
$16.85
Open Price
$17.70
Volume
953.92K
52 Week High
$24.30
52 Week Low
$3.78

OCUL Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.17 per share
Actual
Available Mar 11, After Hours

You May Also Like

UFCS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure